Molecular Pharmaceutics
[ASAP] Mouse Bone Marrow Mesenchymal Stem Cells Inhibit Sepsis-Induced Lung Injury in Mice via Exosomal SAA1
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00542
Molecular Pharmaceutics
[ASAP] Evaluating Spatially Offset Low-Frequency Anti-Stokes Raman Spectroscopy (SOLFARS) for Detecting Subsurface Composition below an Emissive Layer: A Proof of Principle Study Using a Model Bilayer System
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00656
Molecular Pharmaceutics
[ASAP] Development and Evaluation of a Topical Foam Formulation for Decontamination of Warfare Agents
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00636
Molecular Pharmaceutics
[ASAP] Scanning Analysis of Sequential Semisolvent Vapor Impact To Study Naltrexone Release from Poly(lactide-co-glycolide) Microparticles
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00595
Molecular Pharmaceutics
[ASAP] Role of 3D Printing in the Development of Biodegradable Implants for Central Nervous System Drug Delivery
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00344
Molecular Pharmaceutics
[ASAP] Lipid Nanoparticle (LNP) Chemistry Can Endow Unique <italic toggle=”yes”>In Vivo</italic> RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00442
Molecular Pharmaceutics
[ASAP] Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologically Based Models? A Feasibility Study Based on 12 Development Compounds
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00350
Molecular Pharmaceutics
[ASAP] Fabrication and Characterization of Clozapine Nanoemulsion Sol–Gel for Intranasal Administration
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00513
Molecular Pharmaceutics
[ASAP] Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00626
Molecular Pharmaceutics
[ASAP] Purely Predicting the Pharmaceutical Solubility: What to Expect from PC-SAFT and COSMO-RS?
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00573